Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin Effects on Oxidative Stress in High Risk Patients
NCT01322711Phase 4Unknown
- Sponsor
- Sapienza University of Rome
- Start
- Mar 2011
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypercholesterolemia and type 2 diabetes mellitus (T2DM) comparing Atorvastatin with Diet/Placebo (2 arms). Primary endpoints: Serum levels of soluble-gp91phox at 30 days, Systemic and platelet isoprostanes at 30 days and 4 more. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemiatype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01322711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01322711.